---
title: "Pre-market hot trades in US stocks: Coeur Mining pre-market up 4.37%; Thermo Fisher Scientific pre-market down 4.22%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293325396.md"
description: "Coeur Mining pre-market up 4.37%; Thermo Fisher Scientific pre-market down 4.22%; Smart Logistics Global pre-market up 150.17%; Haivision pre-market up 58.05%; DRUGS MADE IN AMER ACQUISITION CORP COM USD0.0001 09/12/2026(S/R) pre-market up 38.18%"
datetime: "2026-07-21T10:22:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293325396.md)
  - [en](https://longbridge.com/en/news/293325396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293325396.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Coeur Mining pre-market up 4.37%; Thermo Fisher Scientific pre-market down 4.22%

**Pre-market Hot Trades in US Stocks**

Coeur Mining pre-market up 4.37%. Based on recent key news:

1.  On July 18, Coeur Mining released preliminary indicators for the second quarter, expecting its oil trading results to remain strong, but the liquefied natural gas business may face a significant decline. This news had a positive impact on the stock price, pushing it up 4.37% in pre-market trading. Source: Zhitong Finance

2.  On July 19, the market saw an increase in demand for physical hedging tools such as gold and silver, providing a structural basis for alternative payments. This increase in demand may have had an indirect impact on Coeur Mining's stock price. Source: Wall Street Insights

3.  On July 21, despite Invivyd Inc facing complex clinical development realities in the biotechnology sector, Lloyds Banking Group committed to providing over £35 billion in new financing for UK businesses, showing strong economic support. This positive macroeconomic signal may have influenced market confidence in Coeur Mining. Source: Jinshi Data, macroeconomic support, enhanced market confidence.

Thermo Fisher Scientific pre-market down 4.22%. Based on recent news,

1.  On July 20, Thermo Fisher Scientific had an annualized return of 14.23% over the past 20 years, performing well in the market, but its current market capitalization is $197.73 billion, with a stock price of $524.11. Despite strong long-term performance, recent market sentiment may have been affected, leading to a decline in stock price.

2.  On July 21, MarketBeat pointed out that although Thermo Fisher Scientific currently has a moderate buy rating among analysts, top analysts believe there are five stocks that are more worthy of investment. This may have weakened investor confidence in Thermo Fisher Scientific, further driving down the stock price. Market sentiment is volatile, and investors should be cautious.

**Top Gainers in Pre-market US Stocks**

Smart Logistics Global pre-market up 150.17%. Based on recent news,

1.  On July 21, Smart Logistics Global announced a strategic cooperation agreement with a major e-commerce platform, expected to significantly enhance the company's business volume and market share, driving a substantial increase in stock price.

2.  On July 20, the company's latest financial report showed that quarterly revenue and net profit exceeded market expectations, further boosting investor confidence and leading to a significant rise in stock price.

3.  On July 19, analysts generally raised their ratings for Smart Logistics Global, believing the company has enormous growth potential in the future, attracting a large amount of buying interest and pushing the stock price up. The logistics industry has performed strongly recently, with robust market demand.

Haiwei Metal Processing pre-market up 58.05%. Based on recent key news:

1.  On July 20, Haiwei Metal Processing released its financial performance for the first quarter of fiscal year 2027, with revenue increasing by 29% year-on-year and gross profit increasing by 58%, restoring operational profitability. The improvement in performance is attributed to product mix optimization and enhanced production efficiency, driving a substantial increase in stock price Source: Company press release

2.  On July 20, the company announced the loss of an important client in its Myanmar business, leading to reduced market concerns about its future growth. Despite facing challenges, the company expressed confidence in adapting and seizing new opportunities. Source: RTT News

3.  On July 18, Hawei Metal Processing reported a decline in net sales to $4.8 million and a net loss of $1.5 million for the fiscal year 2026, due to reduced orders from its Myanmar factory. The company is addressing challenges through acquisitions and diversification strategies. Source: TipRanks Industry trends are positive, macroeconomic stability is evident, and capital inflows are significant.

DRUGS MADE IN AMER ACQUISITION CORP COM USD0.0001 09/12/2026(S/R), pre-market up 38.18%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation

### Related Stocks

- [CDE.US](https://longbridge.com/en/quote/CDE.US.md)
- [TMO.US](https://longbridge.com/en/quote/TMO.US.md)
- [SLGB.US](https://longbridge.com/en/quote/SLGB.US.md)
- [HIHO.US](https://longbridge.com/en/quote/HIHO.US.md)
- [DMAAR.US](https://longbridge.com/en/quote/DMAAR.US.md)

## Related News & Research

- [Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/297086822.md)
- [Insider Selling: Thermo Fisher Scientific (NYSE:TMO) CEO Sells 10,000 Shares](https://longbridge.com/en/news/296877761.md)
- [Thermo Fisher CEO Marc N. Casper sells 275 common shares worth $172,529.69](https://longbridge.com/en/news/297082217.md)
- [Thermo Fisher CEO Marc N. Casper disposes of $15.43 million in common shares](https://longbridge.com/en/news/296823731.md)
- [Solstein Capital LLC Makes New $985,000 Investment in Thermo Fisher Scientific Inc. $TMO](https://longbridge.com/en/news/296769511.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**